Compartmentalization of acyclovir-resistant varicella zoster virus: Implications for sampling in molecular diagnostics

Clinical Infectious Diseases

Volumn 52, Issue 8, 2011, Pages 982-987

  Brink, Antoinette A T P ^a   Van Gelder, Michel ^a   Wolffs, Petra F ^a,b   Bruggeman, Cathrien A ^a,b   Van Loo, Inge H M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET; GANCICLOVIR; THYMIDINE KINASE; VALACICLOVIR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; EARLY DIAGNOSIS; FEMALE; GENE MUTATION; GENETIC CODE; HERPES ZOSTER; HUMAN; MALE; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; VARICELLA ZOSTER VIRUS;

ACYCLOVIR; ADULT; DRUG RESISTANCE, VIRAL; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION, MISSENSE; PATHOLOGY, MOLECULAR; POLYMERASE CHAIN REACTION; THYMIDINE KINASE; TRANSPLANTATION; VIRAL PROTEINS; YOUNG ADULT;

EID: 79953861233     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir079     Document Type: Article

References (30)

1. Han CS, Miller W, Haake R, Weisdorf D. Varicella zoster infection after bone marrow transplantation: incidence, risk factors, and complications. Bone Marrow Transplant 1994; 13:277-83. (Pubitemid 24065953)
2. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010; 48(Suppl 1):S2-7.
3. Snoeck R, Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs 1999; 57:187-206. (Pubitemid 29116508)
4. Talarico CL, Phelps WC, Biron KK. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS. J Virol 1993; 67:1024-33. (Pubitemid 23032082)
5. Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986; 67:1759-816. (Pubitemid 16017266)
6. De Clercq E, Holy A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discov 2005; 4:928-40. (Pubitemid 41637695)
7. Morfin F, Thouvenot D, De Turenne-Tessier M, Lina B, Aymard M, Ooka T. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. Antimicrob Agents Chemother 1999; 43:2412-6. (Pubitemid 29471220)
8. Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J 2008; 27:75-7.
9. Kalpoe JS, Kroes AC, Verkerk S, Claas EC, Barge RM, Beersma MF. Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation. Bone Marrow Transplant 2006; 38:41-6. (Pubitemid 43923088)
10. de Jong MD, Weel JF, van Oers MH, Boom R, Wertheim-van Dillen PM. Molecular diagnosis of visceral herpes zoster. Lancet 2001; 357:2101-2. (Pubitemid 32607456)
11. Linssen CF, Jacobs JA, Stelma FF, et al. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med 2008; 34:2202-9.
12. Vliegen I, Duijvestijn A, Stassen F, Bruggeman C. Murine cytomega-lovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis. Microbes Infect 2004; 6:1056-62. (Pubitemid 39233677)
13. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003; 41:576-80. (Pubitemid 36184164)
14. Hawrami K, Breuer J. Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus. J Virol Methods 1999; 79:33-40. (Pubitemid 29182788)
15. Lacey SF, Suzutani T, Powell KL, Purifoy DJ, Honess RW. Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction. J Gen Virol 1991; 72:623-30.
16. Sawyer MH, Inchauspe G, Biron KK, Waters DJ, Straus SE, Ostrove JM. Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus. J Gen Virol 1988; 69:2585-93.
17. Wolf DG, Lurain NS, Zuckerman T, et al. Emergence of late cyto-megalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 2003; 101:463-5. (Pubitemid 36077564)
18. Blackman SC, Lurain NS, Witte DP, Filipovich AH, Groen P, Schleiss MR. Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency. J Pediatr Hematol Oncol 2004; 26:601-5. (Pubitemid 39223672)
19. de Miranda P, Krasny HC, Page DA, Elion GB. The disposition of acyclovir in different species. J Pharmacol Exp Ther 1981; 219:309-15. (Pubitemid 12252024)
20. Parris DS, Harrington JE. Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates. Antimicrob Agents Chemother 1982; 22:71-7. (Pubitemid 12029996)
21. Malvy D, Treilhaud M, Bouee S, et al. A retrospective, case-control study of acyclovir resistance in herpes simplex virus. Clin Infect Dis 2005; 41:320-6. (Pubitemid 41022108)
22. Gold E. Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection. N Engl J Med 1966; 274:181-5.
23. DE Jong MD, Weel JF, Schuurman T, Wertheim-van Dillen PM, Boom R. Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J Clin Microbiol 2000, 38, 2568-73. (Pubitemid 30485131)
24. Stevens SJ, Verkuijlen SA, Hariwiyanto B, et al. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol 2005; 43:3066-73. (Pubitemid 40981304)
25. Boom R, Sol CJ, Schuurman T, et al. Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented. J Clin Microbiol 2002; 40:4105-13. (Pubitemid 35285797)
26. Nilaver G, Muldoon LL, Kroll RA, et al. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc Natl Acad Sci USA 1995; 92:9829-33.
27. Field AK, Davies ME, DeWitt C, et al. 9-([2-hydroxy-1-(hydrox-ymethyl) ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci USA 1983; 80:4139-43.
28. Steer CB, Szer J, Sasadeusz J, Matthews JP, Beresford JA, Grigg A. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose acy-clovir and ganciclovir. Bone Marrow Transplant 2000; 25:657-64. (Pubitemid 30156592)
29. Koyano S, Suzutani T, Yoshida I, Azuma M. Analysis of phosphor-ylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes. Antimicrob Agents Chemother 1996; 40: 920-3. (Pubitemid 26115225)
30. Suzutani T, Lacey SF, Powell KL, Purifoy DJ, Honess RW. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus. J Virol 1992; 66:2118-24.